NEST:NEONestle S.A. Shs Canadian Depositary Receipt Repr 1 Shs Reg S Analysis
Data as of 2026-03-14 - not real-time
€27.20
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Neste Oyj is trading well above its moving averages, with the 20‑day SMA (≈22.9) comfortably above the 50‑day SMA (≈21.6) and the 200‑day SMA (≈16.9), confirming a strong bullish bias. Technical momentum is reinforced by a bullish MACD crossover (line 1.52 > signal 1.01) and a rising volume trend, yet the RSI sits at an elevated 75.7, flagging potential short‑term overbought conditions as the price nears the recent resistance of €28.04. Volatility is unusually high at nearly 50% over the past 30 days, but the computed beta of 0.21 suggests limited systematic market risk. On the valuation side, the stock trades at a trailing P/E of 151 versus an industry average of 22, and the DCF‑derived fair value of €4.84 is dramatically lower than the current €27.2 price, implying a substantial overvaluation of roughly 18% upside downside. Dividend sustainability is questionable, with a payout ratio exceeding 100% (≈105%) and a modest yield of 0.72%, raising concerns about cash flow coverage. Despite these pricing pressures, the forward EPS outlook improves sharply, driving the forward P/E down to ~17.6, and the company’s renewable diesel and sustainable aviation fuel segments position it for long‑term growth in a decarbonizing economy.
The balance sheet shows €1.37 bn in cash against €5.18 bn of debt, yielding a high debt‑to‑equity of ~71%, while ROE and ROA linger below 2%, indicating modest profitability. Operating cash flow of €1.75 bn and free cash flow of €0.55 bn support ongoing dividend payments but may be strained by the elevated debt load. Sector risk is moderate, with regulatory exposure tied to energy transition policies, yet the company benefits from supportive EU climate incentives. Geographic diversification across Europe and the United States tempers country‑specific risk, though currency exposure to the euro and US dollar introduces a medium‑level currency risk. Overall, the stock’s technical strength is offset by extreme valuation metrics and earnings volatility, suggesting caution in the near term while acknowledging strong long‑run fundamentals.
The balance sheet shows €1.37 bn in cash against €5.18 bn of debt, yielding a high debt‑to‑equity of ~71%, while ROE and ROA linger below 2%, indicating modest profitability. Operating cash flow of €1.75 bn and free cash flow of €0.55 bn support ongoing dividend payments but may be strained by the elevated debt load. Sector risk is moderate, with regulatory exposure tied to energy transition policies, yet the company benefits from supportive EU climate incentives. Geographic diversification across Europe and the United States tempers country‑specific risk, though currency exposure to the euro and US dollar introduces a medium‑level currency risk. Overall, the stock’s technical strength is offset by extreme valuation metrics and earnings volatility, suggesting caution in the near term while acknowledging strong long‑run fundamentals.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- RSI indicating overbought conditions
- Price approaching resistance level
- Extreme valuation relative to DCF
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Bullish MACD and rising volume trend
- Improving forward earnings outlook
- Sustainable fuel market tailwinds
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Strategic positioning in renewable diesel and SAF
- Long‑term growth potential from decarbonisation policies
- Forward P/E compression indicating earnings catch‑up
Key Metrics & Analysis
Financial Health
Revenue Growth-11.00%
Profit Margin0.76%
P/E Ratio151.1
ROE1.96%
ROA1.86%
Debt/Equity70.86
P/B Ratio2.9
Op. Cash Flow€1.7B
Free Cash Flow€554.9M
Industry P/E22.2
Technical Analysis
TrendBullish
RSI75.7
Support€20.16
Resistance€28.04
MA 20€22.92
MA 50€21.57
MA 200€16.85
MACDBullish
VolumeIncreasing
Fear & Greed Index72.88
Valuation
Fair Value€4.84
Target Price€22.16
Upside/Downside-18.52%
GradeOvervalued
TypeGrowth
Dividend Yield0.72%
Risk Assessment
Beta0.21
Volatility49.78%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.